Category Added in a WPeMatico Campaign
Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients [...]
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re committed to providing the highest standard of medical cannabis care, guided by science. As such, we are concerned about the growing number of people buying cannabis from illegal sources, including online [...]
We are thrilled to announce that Curaleaf Clinic won ‘Cannabis Clinic of the Year’ at the Business of Cannabis Awards. Curaleaf International picked up three more awards, including ‘European Cannabis Company of the Year‘. Registered with the Care Quality Commission in 2019, Curaleaf Clinic was the [...]
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions – such as chronic pain, post-traumatic stress disorder (PTSD) and anxiety. We also have a growing number of patients suffering from these conditions who are military veterans. With a special nod to [...]
What is the NHS login? The NHS login is a single, secure login that enables you to swiftly access health and social care apps and websites wherever you see the NHS login button. This is most commonly used to access the NHS app on a computer [...]
At Sapphire Clinics, we see patients with a range of conditions – such as chronic pain, post-traumatic stress disorder (PTSD) and anxiety. We also have a growing number of patients suffering from these conditions who are military veterans. With a special nod to those who have [...]
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do [...]
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do [...]
Sapphire patient, Helen, and Dr James Rucker of Sapphire Medical Clinics spoke to Louise Eccles in The Sunday Times about the rising number of patients prescribed medical cannabis in the UK. Helen explained that “I had taken other medication for my anxiety previously but it gave [...]
Medical cannabis has been available for prescription in the UK since November 2018, and since then an ever-growing number of patients have been able to access these medicines. Now, the UK has approved three vaporisers for the medical use of cannabis, offering specialists doctors the ability [...]
Curaleaf Pharmacy and Sapphire Medical are committed to engaging with patients and families, listen to feedback, and together bring about service improvements that matter to medical cannabis patients. Below are the two new initiatives which add to the existing engagement and education activities. All patients and [...]
New research has been released for patients with Fibromyalgia which has assessed the effects seen in UK patients after being prescribed medical cannabis. Symptoms commonly experienced in Fibromyalgia include anxiety, debilitating fatigue, chronic pain, sensitivity to light, sound, temperature and touch, as well as cognitive symptoms [...]
We asked our team why they enjoyed working at Sapphire and what helping patients safely access medical cannabis means to them. Meet the team and find out more via About Us… The post Meet The Team appeared first on Sapphire Medical Clinics.
Cannabis has been used both recreationally and medicinally for thousands of years, yet the mechanisms through which cannabis compounds affect the human body remain relatively unclear. Many studies have indicated that cannabis may be helpful in the treatment of various medical conditions and illnesses. Cannabidiol – [...]
In recent years, a number of cannabis-based medicinal products have been investigated for their potential in treating symptoms associated with Multiple Sclerosis (MS). Multiple sclerosis is a chronic condition of the nervous system affecting no two patients the same. Common features include visual disturbances, muscle weakness, [...]
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The [...]
As medical cannabis products have gained increasing attention throughout the world, and particularly in the UK, perhaps one of the most discussed areas of research is that of the potential of cannabinoids in Epilepsy treatments. In 2018, the government rescheduled cannabis following in response to evidence [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
